The Cure for Creative Block Creativity is a fickle beast. Sometimes generous while other times fleeting – whether phonetic, audible or visual – unlocking one’s creativity is at the heart of any truly inspirational endeavor. Every person has in them the ability to be creative but for those who make a living of their creativity; what happens when they find themselves wanting? Anything to anyone. There are many flavors of creativity — arguably, any action one undertakes can have a creative twist.
Places we like, DES Daughter's favourite links Diethylstilbestrol DES Journal of a DES Daughter Skip to content Places we like
We've just been
By Karen Nugent
A study published on October 06th, 2011 in the prestigious New England Journal of Medicine tallies the risks of diethylstilbestrol related disorders among women whose mothers took the synthetic hormone during pregnancy, compared to others who weren’t exposed. New study suggests that women exposed to DES are 82% more likely to develop breast cancer after age 40 Among these health risks, the study suggests that women exposed to diethylstilbestrol, commonly called DES daughters, are 82% more likely to develop breast cancer after age 40. Overwhelmed by the extensive media coverage that the publication of this study sparked in the USA, Canada, Australia and France but upset by the total absence of information in the UK, I contacted a health journalist at the UK Press Association to request for this information to be made available to the general public and widely shared and circulated in the UK press. DES Daughters new study suggests lifetime risk of adverse health outcomes
Photos du mur
5 reasons people are ignoring your brand on LinkedIn
Pregnancy Drug Scandal
Twitter Have an account? Sign in New to Twitter? Join Today » Forgot password?
Distilbène® is the trade name for a synthetic hormone (also known internationally as DES or diethylstilbestrol) prescribed in France between 1950 and 1977 to pregnant women to prevent miscarriages. In 1977, 6 years after the U.S. Food and Drug Administration (FDA) advised physicians to discontinue prescribing diethylstilbestrol to pregnant women because of its link to a rare vaginal cancer, UCB Pharma (the manufacturer of Distilbène® in France) decided to make public that the use of this drug was contra-indicated in pregnant women. Distilbène® lawsuits 1991-2011, DES French court cases history
DES drug Quizz; five questions about Diethylstilbestrol Welcome to Survcast! Getting started is easy To review and answer user questions about news - click the surv it or questions button next to any story.
So Long 2011, Hello 2012: 3 ways to get the most out of your New Year! From Dallas to Toronto, Saint John to Vancouver and Victoria — many have struggled through a turbulent 2010 and 2011. Businesses and other organizations have evolved through these difficult times, coming out leaner, meaner and more dedicated to efficient and productive operation than ever before. So what does this mean for your web strategies? Let’s take a look… In the past many businesses have treated their websites as glorified brochures. For many those days are a thing of the past.
Surely this drug
The art of data visualization